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Abstract: Extracellular vesicles (EVs) have been identified as one of the communication mechanisms
amongst embryos. They are secreted into the embryo culture medium and, as such, represent a source
of novel biomarkers for identifying the quality of cells and embryos. However, only small amounts
of embryo-conditioned medium are available, which represents a challenge for EV enrichment.
Our aim is to assess the suitability of different EV separation methods to retrieve EVs with high
specificity and sufficient efficiency. Bovine embryo-conditioned medium was subjected to differential
ultracentrifugation (DU), OptiPrepTM density gradient (ODG) centrifugation, and size exclusion
chromatography. Separated EVs were characterized by complementary characterization methods,
including Western blot, electron microscopy, and nanoparticle tracking analysis, to assess the
efficiency and specificity. OptiPrepTM density gradient centrifugation outperformed DU and SEC
in terms of specificity by substantial removal of contaminating proteins such as ribonucleoprotein
complexes (Argonaute-2 (AGO-2)) and lipoproteins (ApoA-I) from bovine embryo-derived EVs
(density: 1.02–1.04, 1.20–1.23 g/mL, respectively). In conclusion, ODG centrifugation is the preferred
method for identifying EV-enriched components and for improving our understanding of EV function
in embryo quality and development.
Keywords: extracellular vesicles; isolation; protocols; ultracentrifugation; size exclusion chromatography;
OptiprepTM density gradient
1. Introduction
Over the last two decades, extracellular vesicles (EVs) have been recognized as a critical component
of intercellular communication in both physiological and pathological conditions [1]. Interestingly,
they are present in all kinds of biological fluids and contain a myriad of biomolecules, such as proteins,
nucleic acids, and metabolites. Therefore EVs represent a very attractive source of potential biomarkers,
particularly in the enhancement of assisted reproductive technologies (ART) in humans.
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Several sophisticated models based on multivariate parameters of embryo scoring have been
designed to predict pregnancy rates in humans after in vitro fertilization and to optimize the selection
of embryos in specific subgroups of patients [2]. Although these models are a step forward, they still
rely on morphological observations of embryo development and do not take into account the genetic
constitution of the embryo. Embryos carrying chromosomal abnormalities will have a lower chance of
implantation or will lead to a higher percentage of pregnancy loss after implantation [3,4].
Embryonic secretions might predict the true developmental capacity of an embryo. The embryo
culture medium could, therefore, reveal important quality aspects of the embryo that could assist
the selection of the most competent embryos [5]. Recently, our group has demonstrated that bovine
embryos cultured in a group can release functionally active EVs with sizes ranging from 25 to
250 nm. Embryo-derived EVs are possible autocrine embryotropins playing a crucial role in embryo
development [6]. Recently, Giacomini et al. [7] have also shown that conditioned media from human
embryos cultured in vitro for 3 days or up to the blastocyst stage contained EVs with a diameter of 50
to 200 nm.
The separation of EVs still represents a critical step due to several reasons: first, the methods
to isolate EVs are currently highly diverse, and second, depending on which separation method is
employed, the results can be considerably different, even when starting from the same sample [8].
To date, DU is the most popular technique for the separation of EVs, which typically consists of
low-speed centrifugation to remove cells and large vesicles followed by high-speed ultracentrifugation
to pellet EVs [9]. This method relies on sedimentation at high speed for separating EVs from other
(extra)cellular components [10,11]. Density gradient-based centrifugation, using sucrose or iodixanol
(OptiPrepTM), can be utilized to remove contaminating impurities such as non-specific argonaute
proteins, and high-density lipoproteins [8]. Apart from both ultracentrifugation methods, size exclusion
chromatography (SEC) is also commonly used. Size-exclusion chromatography separates EVs from
other media components based on their size, whereby particles with different sizes move through the
filtration column at different rates.
Our aim is to assess the suitability of different methods to separate EVs with maximum specificity
and efficiency from embryo-conditioned medium. We evaluate the impact of three separation
methods (differential ultracentrifugation (DU), OptiPrep™ density gradient ultracentrifugation (ODG),
and size-exclusion chromatography (SEC)) on yield, purity, size, and morphology of EVs secreted by
bovine embryos.
2. Results
A total of 1500 presumed zygotes were cultured in ultracentrifuged SOF + ITS + BSA to attain
3 mL of conditioned medium on Day 8. For each EV separation method, 1 mL of conditioned medium
was used. A schematic representation of the DU, ODG, and SEC isolation protocols used in this study
is shown in Figure 1.
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Figure 1. Schematic overview of three methods to separate EVs from bovine embryo-conditioned 
medium. A total of 1500 presumed zygotes were cultured in groups of 25 in 50 µL droplets of 
ultracentrifuged synthetic oviductal fluid enriched with non-essential and essential amino acids 
(SOFaa), ITS (5 µg/mL insulin; 5 µg/mL transferrin; 5 ng/mL selenium) and medium droplets were 
covered with mineral oil and incubated at 38 °C in 5% CO2, 5% O2, and 90% N2. After 8 days of post 
insemination, the bovine embryo-conditioned medium was pooled and equally divided over three 
separation methods: differential ultracentrifugation (DU), OptiPrepTM density gradient centrifugation 
(ODG), and size exclusion chromatography (SEC). 
2.1. Samples Separated by Differential Ultracentrifugation Contain Contaminants and Aggregates of 
Extracellular Vesicles 
Western blot analysis of EV preparations obtained by differential ultracentrifugation (DU) 
revealed the presence of EV-associated protein CD63 (Figure 2A). The DU pellet also contained high-
density lipoprotein (HDL) marker apolipoprotein A-I (ApoA-I), and argonaute-2 (AGO-2) protein, a 
member of the RNA-induced silencing complex and a well-characterized extracellular RNA-binding 
protein (Figures 2A), indicating contamination of EVs with other extracellular particles. To cross-
check the specificity of the Western blot bands, additional Western blotting was performed with 
incubation of secondary antibodies only (anti-rabbit IgG with 5% BSA for CD63 and anti-mouse IgG 
with 5% milk for ApoA-I and AGO-2). We did not observe any non-specific bands with regards to 
the antibodies CD63 (42 kDa), AGO-2 (97 kDa), and ApoA-I (28 kDa), proving the specificity of the 
primary antibody (see Figure S1). TEM analysis confirmed the presence of EVs of approximately 100 
to 260 nm in size (Figure 2B). In addition, TEM demonstrated the presence of protein aggregates and 
lipoprotein particles (Figure 2B). Next, we quantified the size and concentration of particles in DU 
preparations by NTA (Figure 2C). The particle concentration starting from a pool of 500 embryos was 
3.02 ± 0.36 × 1010 particles/mL, and the mean and mode particle size were 266.8 ± 2.1 and 186.2 ± 21.9 
nm, respectively (as detailed in Table 1, Figure 2C). 
  
Figure 1. Schematic overview of three methods to separate EVs from bovine embryo-conditioned
medium. A total of 1500 presumed zygotes were cultured in groups of 25 in 50 µL droplets of
ultracentrifuged synthetic oviductal fluid enriched with non-essential and essential amino acids
(SOFaa), ITS (5 µg/mL insulin; 5 µg/mL transferrin; 5 ng/mL selenium) and medium droplets were
covered with mineral oil and incubated at 38 ◦C in 5% CO , 5% O2, and 90% N2. After 8 days of post
insemination, the bovine embryo-conditio e e ium was pooled and equally divided over three
separation methods: differ ntial ultracentrifugatio , ptiPrepTM density gradient centrifugation
(ODG), and size exclusion chromatography (SE ).
2.1. Samples Separated by Differential Ultracentrifugation ontain Contaminants and Aggregates of
Extracellular Vesicles
Western blot analysis of EV preparations obtained by ifferential ultracentrifugation (DU) revealed
the presence of EV-associated pr tein CD63 (Figure 2A). The DU pellet also contained high-density
lipoprotein (HDL) marker apolipoprotein A-I (ApoA-I), and argonaute-2 (AGO-2) protein, a member
of the RNA-induced silencing complex and a well-characterized xtrac llular RNA-binding protein
(Figure 2A), indicating contamination of EVs with other extracellular particles. To cross-check the
specificity of the Western blot bands, additional Western blotting was performed with incubation
of secondary antibodies only (anti-rabbit IgG with 5% BSA for CD63 and anti-mouse IgG with
5% milk for ApoA-I and AGO-2). We did not observe any non-specific bands with regards to the
antibodies CD63 (42 kDa), AGO-2 (97 kDa), and ApoA-I (28 kDa), proving the specificity of the
primary antibody (see Figure S1). TEM analysis confirmed the presence of EVs of approximately 100
to 260 nm in size (Figure 2B). In addition, TEM demonstrated the presence of protein aggregates and
lipoprotein particles (Figure 2B). Next, we quantified the size and concentration of particles in DU
preparations by NTA (Figure 2C). T particle conc ntration starting from a pool of 500 embryos
was 3.02 ± 0.36 × 1010 part cles/mL, and the mean and mode particle size were 266.8 ± 2.1 and
186.2 ± 21.9 nm, respectively (as detailed in Table 1, Figure 2C).
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Table 1. Comparison of extracellular vesicle isolation methods by time, price, and nanoparticle 
analysis. 
Isolation 
Technique 
DU ODG  SEC  
Working Principle 
EV isolation is based on 
sequential centrifugation steps 
to exclude large vesicles and 
cells debris and precipitate EVs 
Combination of 
ultracentrifugation with 
sucrose gradient 
EV isolation is based on the size 
difference between EVs and other 
particulate constituents 
Total time (h) 5 22 2 
Approximate 
price/sample (€) 
5 15 5 
Nanoparticle Data  DU EVs 
OGD EVs  
(8–9 Fraction) 
SEC EVs Fractions 
   SEC 9 SEC 10 SEC 11 
Mean 266.8 ± 2.1 nm 151.3 ± 8.8 nm 
108.3 ± 
6.8 nm 
119.2 ± 
3.5 nm 
97.9 ± 2.2 
nm 
Mode 186.1 ± 21.9 nm 100.1 ± 20.4 nm 
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7.0 nm 
99.7 ± 6.0 
nm 
68.4 ± 4.0 
nm 
SD 91.2 ± 2.8 nm 53.9 ± 26.3 nm 
34.9 ± 4.3 
nm 
52.4 ± 6.9 
nm 
39.4 ± 3.3 
nm 
D10 149.8 ± 2.3 nm 86.7 ± 18.9 nm 
75.1 ± 7.0 
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74.8 ± 3.6 
nm 
62.7 ± 4.1 
nm 
D50 264.5 ± 5.3 nm 127.9 ± 6.5 nm 101.1 ± 
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104.3 ± 
3.8 nm 
86.4 ± 4.4 
nm 
D90 397.3 ± 9.1 nm 211.8 ± 39.8 nm 
150.6 ± 
6.9 nm 
173.8 ± 
8.5 nm 
145.4 ± 
5.8 nm 
Nanoparticles/mL 3.02 ± 0.36 × 1010 5.50 ± 2.70 × 109 
2.09 ± 
0.46 × 
1010 
1.50 ± 
0.43 × 
1011 
1.13 ± 
0.11 × 
1010 
Total time required (i.e., based on ease-of-use, turn-around time, hands-on time) and approximate 
cost per sample (i.e., based on the cost of centrifuge tubes and required solutions). The mode, mean 
value, standard deviation of size, and concentration for each EV isolation from 500 embryo culture 
medium method are provided. The value D50 represents the median size. Similarly, 90 percent of the 
distribution lies below the D90 value, and 10 percent of the population lies below the D10 value. 
 
 
Figure 2. Characterization of DU-EVs derived from bovine embryo-conditioned medium. (A) Western
blot analysis of EV-associated protein CD63 (42 kDa) and non-EV associated proteins (ApoA-I (28 kDa)).
(B) Transmission electron microscopy pictures of DU-EVs with white arrows representing protein
aggregates and black arrows indicating EVs. Scale bar = 100/200 nm. (C) Size distribution profile of
DU-EVs determined by NTA. Abbreviations: DU = differential ultracentrifugation; +ctr = follicular
fluid derived EVs by OptiPrepTM density gradient; L = marker (protein ladder).
Table 1. Comparison of extracellular vesicle isolation methods by time, price, and nanoparticle analysis.
Isolation
Technique DU ODG SEC
Working Principle
EV isolation is based
on sequential
centrifugation steps to
exclude large vesicles
and cells debris and
precipitate EVs
Combination of
ultracentrifugation
with sucrose
gradient
EV isolation is based on the size difference between EVs and
other particulate constituents
Total time (h) 5 22 2
Approximate
price/sample (€) 5 15 5
Nanoparticle Data DU EVs OGD EVs(8–9 Fraction) SEC EVs Fractions
SEC 9 SEC 10 SEC 11
Mean 266.8 ± 2.1 nm 151.3 ± 8.8 nm 108.3 ± 6.8 nm 119.2 ± 3.5 nm 97.9 ± 2.2 nm
Mode 186.1 ± 21.9 nm 100.1 ± 20.4 nm 102.3 ± 7.0 nm 99.7 ± 6.0 nm 68.4 ± 4.0 nm
SD 91.2 ± 2.8 nm 53.9 ± 26.3 nm 34.9 ± 4.3 nm 52.4 ± 6.9 nm 39.4 ± 3.3 nm
D10 149.8 ± 2.3 nm 86.7 ± 18.9 nm 75.1 ± 7.0 nm 74.8 ± 3.6 nm 62.7 ± 4.1 nm
D50 264.5 ± 5.3 nm 127.9 ± 6.5 nm 101.1 ± 7.7 nm 104.3 ± 3.8 nm 86.4 ± 4.4 nm
D90 397.3 ± 9.1 nm 211.8 ± 39.8 nm 150.6 ± 6.9 nm 173.8 ± 8.5 nm 145.4 ± 5.8 nm
Nanoparticles/mL 3.02 ± 0.36 × 1010 5.50 ± 2.70 × 109 2.09 ± 0.46 × 1010 1.50 ± 0.43 × 1011 1.13 ± 0.11 × 1010
Total time required (i.e., based on ease-of-use, turn-around time, hands-on time) and approximate cost per sample
(i.e., based on the cost of centrifuge tubes and required solutions). The mode, mean value, standard deviation of
size, and concentration for each EV isolation from 500 embryo culture medium method are provided. The value D50
represents the median size. Similarly, 90 percent of the distribution lies below the D90 value, and 10 percent of the
population lies below the D10 value.
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2.2. Size Exclusion Chromatography does not Separate Protein Aggregates and Lipoprotein Particles from
Extracellular Vesicles
Western blot analysis identified EV-associated protein CD63 across fractions 9 to 11. In addition,
the majority of argonaute-2 (AGO-2) protein and apolipoprotein A-I (ApoA-I) was detected in fractions
9 to 11 (Figure 3A). Additional Western blotting analysis with secondary antibody (anti-rabbit IgG
with 5% BSA for CD63 and anti-mouse IgG with 5% milk for ApoA-I, AGO-2) incubation showed
some non-specific bands in the fractions of SEC 1 to 8 and SEC 10 (see Figure S2). No bands were
observed with regards to ApoA-I (28 kDa), AGO-2 (97 kDa), and CD63 (42 kDa) from fractions 1 to 8
and fraction 10, proving the specificity of the primary antibody (Figure 3A). TEM analysis of fraction 10
confirmed the presence of EVs approximately 25 to 250 nm in size and protein aggregates (Figure 3B).
SEC fraction 10 showed the highest particle concentration with 1.50 ± 0.43 × 1011 particles/mL starting
from a pool of 500 embryos with a mean particle size of 119.2 ± 3.5 nm and a mode of 99.7 ± 6.0 nm as
measured by NTA (Table 1, Figure 3C).
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arrows representing protein aggregates and black arrows indicating EVs. Scale bar = 100/200 nm. (C) 
Size distribution profile of SEC-EVs determined by NTA. Abbreviations: SEC 1 = size exclusion 
chromatography fraction 1 (similar for 2 to 16 fractions); +ctr = follicular fluid derived EVs by 
OptiPrepTM density gradient; L = marker (protein ladder). 
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Next, we analyzed the specificity of ODG centrifugation for enriching EVs from bovine embryo-
conditioned medium. Western blot analysis identified EV-associated protein CD63 density fractions 
8 and 9, corresponding to a density of 1.086–1.119 g/mL (Figure 4A). By contrast, the majority of 
argonaute-2 (AGO-2) protein and apolipoprotein A-I (ApoA-I) were detected in, respectively, 
fractions 1 to 4 and 5 to 7 (density: 1.02–1.04, 1.20–1.23 g/mL, respectively; Figure 4A). There are some 
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secondary antibody Western blotting analysis (see Figure S1), whereas no additional bands were 
observed with regards to primary antibody incubation proving the specificity of AGO-2 antibody 
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Figure 3. Characterization of SEC-EVs derived from bovine embryo-conditioned medium. (A) Western
blot analysis of EV-associated protein CD63 (42 kDa) and non-EV associated proteins (ApoA-I
(28 kDa), Ago-2 (97 kDa)). (B) Transmission electron microscopy pictures of SEC-EVs with white
arrows representing protein aggregates and black arrows indicating EVs. Scale bar = 100/200 nm.
(C) Size distribution profile of SEC-EVs determined by NTA. Abbreviations: SEC 1 = size exclusion
chromatography fraction 1 (similar for 2 to 16 fractions); +ctr = follicular fluid derived EVs by
OptiPrepTM density gradient; L = marker (protein ladder).
2.3. OptiPrepTM Density Gradient Centrifugation Separates Extracellular Vesicles with Higher Specificity
Compared to DU and SEC
Next, we analyzed the specificity of ODG centrifugation for enriching EVs from bovine
embryo-conditio ed medium. Western blot analysis identified EV-associated protein CD63 density
fractions 8 and 9, corresponding to a density of 1.086–1.119 g/mL (Figure 4A). By contrast, the majority of
argo aute-2 (AGO-2) protein an apolipoprotein A-I (ApoA-I) were detected in, respectively, fractions 1
to 4 and 5 to 7 (density: 1.02–1.04, 1.20–1.23 g/mL, respectively; Figure 4A). There are some non-specific
bands (~80 kDa) i the sample fraction of ODG 1–4 and a positive control sample of the secondary
a tibody Wester blotting analysis (see Figure S1), whereas no additional bands were observed
with regards to primary antibody incubation proving the specificity of AGO-2 antibody (Figure 4A).
The TEM analysis of density fractions 8 an 9 confirmed the presence of EVs of approximately 25
to 250 nm in size (Figure 4B). The particle distributio assessed by NTA ranged from 25 to 300 nm,
with a mean particle size of 151.3 ± 8.8 nm, mode of 100.1 ± 20.4 nm, and a particle concentratio of
5.50 ± 2.70 × 109 particles/mL, starting from a pool of 500 embryos (Table 1, Figure 4C).
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Figure 4. Characterization of ODG-EVs derived from bovine embryo-conditioned medium. (A) Western
blot analysis of EV-associated protein CD63 (42 kDa) and non-EV associated proteins -I (28
kDa), Ago-2 (97 kDa)). (B Transmi sion electron micros pictures of ODG-EVs with white
arrows representi g protein aggregates and black arrows indicating EVs. Scale bar = 100/200 nm.
(C) Size distribution profile of ODG-EVs determined by NTA. Abbreviations: DU = differential
ultracentrifugation; ODG 1–4 = OptiPrepTM density gradient fractions 1 to 4 (similar for 5–7, 8–9.
10–12, 13–16); +ctr = follicular fluid derived EVs by ODG, L = marker (protein ladder), +Neg ctr = EVs
derived from Lysate HEK 293T, +Positive ctr = Plasma pure.
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3. Discussion
There is a growing need for a standardized method to prepare EVs with sufficient specificity and
efficiency. Multiple studies comparing different methods for separation of EVs from biological fluids
and cell culture media have been published [8,12,13]. Such a comparison for medium conditioned
by embryos has not been performed yet. Here, we assessed the efficiency of different EV separation
methods, including DU, ODG centrifugation, and SEC. We show that ODG centrifugation separated
EVs from bovine embryo-conditioned media with higher specificity compared to DU and SEC. As has
been demonstrated by previous studies [8,14], ODG depletes EV samples from ribonucleoprotein
complexes (argonaute-2) and lipoprotein particles (apolipoprotein A-I (ApoA-I)). In agreement with
our findings, Van Deun et al. [8] also reported the presence of AGO-2 protein in EVs obtained by DU.
In addition, DU may yield EV aggregates after pelleting [10,11,15,16]. Alternatively, it may enrich for
larger EVs that sediment more efficiently. ODG centrifugation separates a wide range of smaller to
larger EVs with high efficiency, confirming the results by Van Deun et al. [8].
When using ODG and SEC, the vesicle structure and integrity of EVs remain largely intact, and
the biological activity of EVs is preserved. The size distribution profile of SEC- and ODG-derived EVs
differed from DU-derived EVs, as SEC- and ODG-derived EVs were found to be smaller in size compared
to DU-derived EVs. Larger size vesicles derived by DU may be the result of aggregation or fusion of
EVs during ultracentrifugation, as also suggested by others [10,17,18]. The major disadvantages of
using SEC methods are the co-precipitation of other extracellular particles like lipoprotein particles
and ribonucleoproteins, as demonstrated per the current study. These findings are in accordance
with Takov et al. [19,20], who demonstrated that lipoproteins are co-isolated with SEC-EVs derived
from plasma.
One of the major challenges in isolating EVs is the input volume of embryo culture medium.
Earlier, Mellisho et al. [21] have demonstrated that 500 µL of medium conditioned by bovine blastocysts
was sufficient for EV isolation, but apparently, in this study, no standardized EV isolation method
was applied. In our previous study, initially, we used 500 µL of embryo-conditioned medium, but
this was not sufficient for either characterization or quantification of EVs [6]. In conclusion, the
separation of EVs with high specificity from 1 mL of embryo culture medium was addressed in the
current study. Our analyses highlight the ODG centrifugation method as the most suitable procedure
for EV enrichment that results in greater purity than DU and SEC. ODG centrifugation will allow
the improved identification of EV-associated molecules that may further be used as biomarkers for
embryo quality.
4. Material and Methods
4.1. In Vitro Embryo Production
Routine in vitro methods were used for bovine embryo production, as described previously by
Pavani et al. [6]. Briefly, at the local abattoir, cow ovaries were obtained and processed within 2 h after
collection. Upon arrival at the lab, ovaries were washed three times in warm physiological saline (with
kanamycin (25 mg/mL)). Cumulus-oocyte complexes (COCs) were aspirated from antral follicles sizing
between 4 and 8 mm diameter using an 18-gauge needle attached to a 10-mL syringe. Subsequently,
only oocytes with uniformly granulated cytoplasm and surrounded by more than three compact layers
of cumulus cells were cultured in groups of 60 COCs in 500 mL modified bicarbonate buffered TCM-199
(supplemented with 50 mg/mL gentamicin and 20 ng/mL epidermal growth factor) in 5% CO2 in air
for 22 h at 38.5 ◦C.
Frozen-thawed bull spermatozoa were separated using a 45/90% Percoll® gradient (GE
Healthcare Biosciences, Uppsala, Sweden). Next, the sperm pellet was washed in IVF–Tyrode’s
albumin–pyruvate–lactate (TALP) medium, containing bicarbonate-buffered Tyrode solution. Then, it
was adjusted to a final concentration of 1 × 106 spermatozoa/mL using IVF–TALP medium enriched
with BSA (Sigma A8806; 6 mg/mL) and heparin (25 mg/mL).
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After 22 h maturation, bovine oocytes were washed in 500 µL IVF–TALP and subsequently
co-incubated with Percoll® washed bull spermatozoa. After 21 h gamete co-incubation, presumed
zygotes were vortexed to remove surplus zona attached cumulus and sperm cells. The presumed
zygotes were cultured in groups of 25 in 50 µL droplets of ultracentrifuged synthetic oviductal
fluid enriched with non-essential and essential amino acids (SOFaa), ITS (5 µg/mL insulin; 5 µg/mL
transferrin; 5 ng/mL selenium) and medium droplets were covered with mineral oil and incubated at
38 ◦C in 5% CO2, 5% O2, and 90% N2.
4.2. Collection of Culture Media Conditioned by Bovine Embryos
Culture medium conditioned by bovine embryos was collected and pooled in preparation for
EV isolation. Per embryo culture replicate, a group of 100 presumed zygotes was cultured in SOF +
ITS + BSA culture medium (UC BSA medium; 25 zygotes per 50 µL droplet depleted from EVs after
100,000× g of ultracentrifugation for 18 h at 4 ◦C). On 8 dpi, 200 µL embryo-conditioned medium was
collected and stored at −80 ◦C. To obtain 3 mL of embryo-conditioned culture medium, 15 replicates
were performed with a total of 1500 presumed zygotes. One mL of pooled embryo-conditioned
medium was used for each EV isolation method (differential ultracentrifugation, OptiPrep™ density
gradient ultracentrifugation, and size-exclusion chromatography; as detailed in Figure 1).
4.3. Differential Ultracentrifugation
Differential ultracentrifugation was performed as described previously by Théry et al. [9] with a few
modifications. Briefly, 1 mL of embryo-conditioned medium was diluted to 5 mL in phosphate-buffered
saline (PBS) (Invitrogen), transferred to a 5.2-mL open-top polyallomer centrifuge tube (Beckman
Coulter, Fullerton, CA, USA) and centrifuged for 7 min at 10,000× g and 4 ◦C in a swinging bucket
centrifuge (Optima XPN-80, SW 55 Ti rotor, Beckman Coulter). The pellet was discarded, and the
supernatant was centrifuged for 30 min at 30,000× g and 4 ◦C, again the pellet was discarded, and the
supernatant was centrifuged for 3 h at 100,000× g and 4 ◦C. The pellet was resuspended in 100 µL of
PBS and stored at −80 ◦C for further EV characterization.
4.4. OptiPrepTM Density Gradient Ultracentrifugation
OptiPrep™ density gradient (ODG) ultracentrifugation was conducted, as previously reported
by Van Deun et al. [8]. Briefly, appropriate amounts of a homogenization buffer (10 mM Tris-HCl
(tromethamine-hydrochloric acid), 1 mM EDTA (Ethylenediaminetetraacetic acid) and 0.25 M sucrose
(pH 7.4)) and an iodixanol working solution were mixed in order to prepare 5%, 10%, 20%, and 40%
iodixanol solutions. The iodixanol working solution was made by adding a working solution buffer
(60 mM Tris-HCl, 6 mM EDTA, 0.25 M sucrose (pH 7.4)) to a stock solution of OptiPrep™ (60% (w/v)
aqueous iodixanol solution). Moreover, the gradient was prepared in a 16.8 mL open-top polyallomer
tube (Beckman Coulter) by layering 4 mL of 40%, 4 mL of 20%, 4 mL of 10%, and 3.5 mL of 5% solutions
on top of each other. One mL of embryo-conditioned medium was overlaid onto the top of the gradient.
Subsequently, the gradient was centrifuged at 4 ◦C for 18 h at 100,000× g (SW 32.1 Ti rotor, Beckman
Coulter). Then, all 16 gradient fractions were divided into six samples by pooling the fractions 1–4,
5–7, 8–9, 10–12, 13–16, respectively. The pooled fractions were added to 14 mL PBS. Subsequently,
the separate suspensions were centrifuged at 4 ◦C for 3 h at 100,000× g. The resulting pellets were
resuspended in 100 µL PBS and stored at −80 ◦C for further EV characterization.
4.5. Size-Exclusion Chromatography
Sepharose CL-2B (GE Healthcare, Uppsala, Sweden) was washed three times with PBS containing
0.32% trisodium citrate dihydrate (ChemCruz, Dallas, TX, USA) [22,23]. For the preparation of one
column, nylon net with 20 µm pore size (NY2002500, Merck Millipore, Billerica, MA, USA) was placed
on the bottom of a 10-mL syringe (BD Biosciences, San Jose, CA, USA), followed by stacking of 10 mL
Sepharose CL-2B. On top of the SEC column, 1 mL of embryo-conditioned medium was loaded and
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fractions of 1-mL eluate were collected in 16 fractions. Resulting fractions were concentrated with
Amicon Ultra-2 10 k centrifugal filters (UFC201024, Merck Millipore, Billerica, MA, USA) as previously
described by Pavani et al. [6] and the eluates of each fraction were retrieved from the flow-through
reservoir and stored at −80 ◦C for further EV characterization.
4.6. Characterization of Extracellular Vesicles
4.6.1. Western Blotting
All samples were suspended in a reducing buffer (0.005% bromophenol blue, 3% 2-mercaptoethanol,
9.2% SDS, 40% glycerol, and 0.5 M Tris-HCl (pH 6.8)) and boiled for 5 min at 95 ◦C. Protein samples were
separated by SDS polyacrylamide gel electrophoresis and subsequently transferred to a nitrocellulose
membrane (Bio-Rad, Hercules, California, USA). Next, the membrane was blocked at room temperature
with 5% skim milk/BSA TBST for 45 min. Subsequently, the membranes were exposed to CD63 rabbit
(1:200 in 5% BSA + 0.5% Tween PBS ab68418, Abcam, Cambridge, UK), AGO-2 rabbit (1:1000 in 5%
milk + 0.5% Tween PBS, ab32381, Abcam, Cambridge, UK), and ApoA-I mouse (1:1000 in 5% milk
+ 0.5% Tween PBS, sc-376818, Santa Cruz, CA, USA), primary antibodies at 4 ◦C. After overnight
incubation, the membranes were extensively washed with 0.5% Tween in PBS. Then, the membranes
were incubated with the appropriate secondary antibodies (anti-mouse IgG (GE Healthcare, UK),
1:3000 in 5% milk + 0.5% Tween PBS; anti-rabbit IgG (GE Healthcare, UK), 1:4000 in 5% BSA + 0.5%
Tween PBS. After a final wash step, chemiluminescence substrate (WesternBright Sirius, Advansta,
Menlo Park, California, USA) was added to the membranes. Imaging was performed using Proxima
2850 Imager (IsoGen Life Sciences, De Meern, The Netherlands).
4.6.2. Transmission Electron Microscopy
For transmission electron microscopy, each sample was deposited on precoated formvar/carbon
support film copper mesh electron microscopy grids (FCF200H-CU-TB; Aurion, Netherlands). Grids
were labeled for 45 s with 1% uranyl acetate (in double-distilled water). Prepared grids were examined
using electron microscopy (JEM 1400 plus, JEOL, Benelux; and Ziess EM 109, Carl Zeiss, Jena, Germany).
Moreover, images were made by Quemasa charge-coupled device camera (Olympus Soft Imaging
solutions GMBH, Munster, Germany).
4.6.3. Nanoparticle Tracking Analysis
Samples were analyzed by nanoparticle tracking analysis (NTA) using the NanoSight LM10
microscope (Malvern Instruments Ltd., Malvern, UK) equipped with a 455-nm laser. For each individual
sample, three videos of 60 s were recorded and analyzed with detection threshold 3 and camera
level 13. All videos were analyzed by NTA Software version 3.2. To achieve optimal measurements,
all EV samples were diluted with PBS to obtain a particle concentration within the optimal range
(3 × 108–1 × 109) of the NTA Software. Graphical presentations were performed using GraphPad
Prism version 7.05 (GraphPad Software, San Diego, California, USA).
4.6.4. EV-Track
We have submitted all relevant data of our experiments to the EV-TRACK knowledgebase
(EV-TRACK ID: EV190022; Consortium et al. [24] EV-TRACK: transparent reporting and centralizing
knowledge in extracellular vesicle research). The EV-METRIC score is 78%.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/8/2942/s1.
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